Foundayo weight loss (obesity)
orforglipron · made by Eli Lilly · oral pill (daily)
Verified June 2026Approved forweight loss (obesity)
List priceself-pay from $149/mo
Cheapest legitimate cash path
Self-pay from $149/mo (lowest dose); as little as $25/mo with a commercial-insurance savings card; ~$50/mo for eligible Medicare Part D via the GLP-1 Bridge. Source: Eli Lilly — Foundayo (orforglipron) oral GLP-1 pill approved & available ↗
Good to know
FDA-approved Apr 1 2026 — the first GLP-1 PILL for weight loss, taken any time of day with no food/water restrictions (~27 lb average at the highest dose). Boxed warning: thyroid C-cell tumors (MTC); not for anyone with a personal/family history of MTC or MEN 2.
How to pay less
- Insurance + appeal if denied usually beats any cash price.
- Medicare Part D: the GLP-1 Bridge (from July 1, 2026).
- Medicaid: status varies by state.